Sign up
Quantellect · Congress · Congressional Trade

Tom Malinowski bought Profound Medical Corp (NASDAQ: PROF)

Tom Malinowski bought Profound Medical Corp (PROF), disclosed August 26, 2021

Tom Malinowski bought PROF · disclosed August 26, 2021

Tom Malinowski, a NJ House member representing District 7, purchased $1,001 - $15,000 of Profound Medical Corp (PROF) on January 27, 2020. Filings associated with Tom Malinowski disclosed 2 other PROF transactions (2 purchases) in the 12 months before this trade. Shares of PROF have fallen 35.4% since the first observed purchase on December 20, 2019. The filing was publicly disclosed on August 26, 2021; a direct filing link is not available in the current data record.

Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Tom Malinowski's complete filing history, visit Tom Malinowski's full trade history. Browse all trading members of Congress tracked by Quantellect.

Key points

  • Analyst ratings on PROF break down as 0 strong buy, 1 buy, 0 neutral, 0 sell, 0 strong sell.
  • PROF carries a Risk Score of 73 as of November 20, 2026. On this scale, a higher score means a lower risk surface.
  • Tom Malinowski bought PROF in the amount range of $1,001 - $15,000 on January 27, 2020, filed under the STOCK Act.
  • The filing lists Self as the transaction owner and was disclosed n/a after the trade.
  • The asset description in the filing reads 'Profound Medical Corp. - common stock (PROF) [ST] F IlINg S TATuS : New.'
  • Filings associated with Tom Malinowski disclosed 2 other PROF transactions (2 purchases) in the 12 months before this trade.
  • Shares of PROF have fallen 35.4% since the first observed purchase on December 20, 2019.
  • PROF carried a Q Score of 0 in its equity peer group as of date unavailable.
  • PROF carried a Squeeze Score of 38 as of November 22, 2026.

Did Tom Malinowski buy or sell PROF?

The Periodic Transaction Report covers a single purchase involving PROF on January 27, 2020. The filed amount range is $1,001 - $15,000. The asset description reads 'Profound Medical Corp. - common stock (PROF) [ST] F IlINg S TATuS : New', as submitted by the filer. The report was submitted on August 26, 2021. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.

PoliticianActionTickerAmountTrade dateFiled
Tom Malinowski (House)BuyPROF$1,001 - $15,000January 27, 2020August 26, 2021

What other PROF trades has Tom Malinowski disclosed in the past 12 months?

Filings associated with Tom Malinowski disclosed 2 other PROF transactions (2 purchases) in the 12 months before this trade.

Trade dateActionOwnerAmountFiling
January 14, 2020BuySelf$1,001 - $15,000Filing unavailable
December 20, 2019BuySelf$1,001 - $15,000Filing unavailable

What does the filing show, and what does it not show?

The filing reports a purchase involving PROF by Tom Malinowski in the amount range of $1,001 - $15,000, with Self listed as the owner. It does not establish Tom Malinowski's total holdings in PROF, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Profound Medical Corp. - common stock (PROF) [ST] F IlINg S TATuS : New', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Tom Malinowski's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Tom Malinowski disclosed 2 other PROF transactions (2 purchases) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.

Who else in Congress traded PROF?

Quantellect's current database lists these recent PROF disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.

MemberPartyActionAmountDisclosed
No recent disclosures by other members are available.

How has Tom Malinowski's disclosed trading performed?

A current measured Member Score is not available for this member. Quantellect does not infer performance where the scored-trade projection lacks coverage.

All Tom Malinowski PROF trades

TradedTypeSizeReturnEst. profit
July 21, 2020Buy$1,001 - $15,000-59.82%-$5K
January 27, 2020Buy$1,001 - $15,000-46.74%-$4K
January 14, 2020Buy$1,001 - $15,000-49.53%-$4K
December 20, 2019Buy$1,001 - $15,000-35.36%-$3K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Frequently asked questions

Did Tom Malinowski buy or sell PROF?

According to the disclosure, Tom Malinowski purchased PROF on January 27, 2020.

What amount was reported for the PROF transaction?

The disclosure reports $1,001 - $15,000 for the purchase. Filed amounts are ranges, not exact transaction values.

When did the transaction occur, and when was it disclosed?

The transaction is dated January 27, 2020, and it was disclosed on August 26, 2021.

Where can I see Tom Malinowski's other congressional trades?

Quantellect lists Tom Malinowski's complete disclosed trade history on the member profile. Tom Malinowski's trade history

Is congressional stock trading legal?

The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act

Is Congress exempt from insider trading laws?

No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act

How quickly must members of Congress disclose a trade?

Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance

How is net worth reported in these disclosures?

It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act

Like this article? Share it
Methodology & disclaimer. Trades reflect Periodic Transaction Reports filed under the STOCK Act of 2012, which requires members of Congress to disclose covered transactions, generally within 30 days of receiving notice of the transaction and no later than 45 days after the transaction; disclosed amounts are the broad ranges in the official filing, not exact figures. Estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended. The Member Score measures a member's disclosed-trade track record against a sector-matched benchmark. This article is generated programmatically for education and research only. It is not investment advice, a recommendation, or an allegation of unlawful trading.

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.